Not all Platelet Rich Plasma (PRP) injections are the same – and the difference that matters most is platelet dose, not “5× PRP” marketing. PRP is a dose-dependent biologic treatment: the clinical effect depends on how many platelets are actually injected into the target tissue, which is calculated as platelet concentration × injection volume. This is why some PRP treatments underperform despite impressive-sounding concentration claims, and why high-dose PRP approaches (especially in knee osteoarthritis) are increasingly associated with better, longer-lasting outcomes when the delivered platelet dose reaches meaningful thresholds. If you’re comparing PRP clinics, ask for the numbers that define quality: measured platelet concentration, injected volume, and total platelet dose delivered.
PRP 101: Concentration is not dose
Most marketing focuses on “high concentration PRP” (e.g., “5x” or “10x”). That sounds impressive, but it can be misleading.
Why?
Because dose = concentration × volume injected.
Platelet dose is the total number of platelets injected.
What determines the biological power of PRP is the actual number of platelets delivered into the tissue – the platelet dose [1-4]. Platelet concentration alone (e.g., “5× baseline”) is not enough, because concentration doesn’t tell you how many platelets were injected. A small injection volume, even at a moderate or high concentration, can still deliver an underpowered platelet dose. That’s why modern PRP literature increasingly emphasises dose rather than “× baseline” claims: the most defensible metric is total platelets delivered, calculated as platelet concentration × injected volume. In other words, if you don’t know the concentration and the volume, you can’t know the dose – and you can’t meaningfully compare PRP treatments.
Clinically, platelet dose can be measured directly (Complete Blood Count (CBC)/automated platelet count of the final PRP), or estimated from validated device yield data combined with baseline whole-blood platelet count and final PRP volume – but either way, the goal is the same: know the total platelets delivered.
The clinical signal: higher platelet dose is linked to better outcomes
In knee osteoarthritis (the most studied PRP indication), dose-response evidence is particularly strong [5,6].
A randomized trial compared PRP (formulated to deliver 10 billion platelets) to hyaluronic acid and found sustained improvements at 1 year, concluding that an absolute count of 10 billion platelets was crucial for long-term chondroprotective effect in moderate knee OA [7].
A systematic review/meta-analysis of musculoskeletal PRP literature also reports a dose-response relationship and highlights an optimal threshold >10 billion platelets for favourable clinical outcomes in knee OA [6].
The practical takeaway isn’t that every tissue requires the same number. It’s that platelet dose is a primary driver of outcomes, and under-dosed PRP is often biologically underpowered -regardless of how it’s marketed. The best dose-threshold signal we currently have is in moderate knee osteoarthritis, where multiple studies suggest that longer-term outcomes improve when the injected dose reaches around ~10 billion platelets, implying a meaningful minimum threshold for that indication.
Why “not all PRPs are the same” is scientifically true
PRP varies because preparation systems and protocols vary – dramatically.
Different devices can produce platelet concentrations that are lower than baseline, while dual-spin systems can produce very high platelet concentrations. Dual-spin methods are also associated with higher VEGF and PDGF compared with single-spin methods, likely due to higher platelet capture rates [1].
And composition matters beyond platelets:
- Leukocytes: may influence inflammation (sometimes considered helpful, sometimes considered harmful depending on tissue and pathology) [3].
- Red blood cell contamination: can be undesirable (many contemporary dosing reviews advise keeping PRP as RBC-free as possible) [7].
- Preparation quality: even the anticoagulant used can affect platelet viability and growth factor retention (eg, ACD is generally preferred for PRP platelet integrity and growth factor release) [references].
This is exactly why modern authors call for standardisation and more rigorous reporting: without it, PRP studies (and real-world outcomes) become incomparable [3,4].
Estimated Platelet Dose by PRP System (based on whole-blood input)
PRP is a dose-dependent biologic, yet the commercial market often describes it using brand names, “× baseline” concentration claims, or generic terms like “high-strength PRP,” which are not dose metrics. In reality, PRP performance is driven by measurable variables — whole-blood input volume, platelet recovery efficiency, final injectate volume, and the resulting total platelet dose delivered. Recovery rates do vary between devices and between patients, and closed systems also carry practical advantages (notably reduced handling and, in principle, lower contamination risk). But the brand itself is not what makes PRP effective.
Because marketing language frequently obscures these technical differences, we’ve included a side-by-side comparison of several commonly used systems to illustrate how device design and processing volume can influence the maximum achievable platelet dose — the parameter most closely linked to clinical efficacy in multiple musculoskeletal indications.
These are theoretical dose ceilings based on published/claimed recovery and baseline platelet ranges; actual injected dose should be measured.
Table: PRP Kit Comparison: Estimated Platelet Dose by System
| PRP system | Whole blood processed | Platelet recovery used | Estimated platelet dose (billions) low–mid–high* |
| EmCyte (double spin) [9-11] | 120 mL | 0.90 (claimed “up to”) | 13.5 – 21.6 – 29.7 B |
| Alocuro (30 mL kit) [12-14] | 30 mL | 0.90 (claim) | 3.38 – 5.40 – 7.43 B |
| RegenLab (10 mL) [15-16] | 10 mL | 0.80 (≥80% claim) | 1.00 – 1.60 – 2.20 B |
| Surecell (tube-based) [17] | Example 16 mL (2×8 mL tubes) | 0.70 (illustrative only – no data available) | 1.40 – 2.24 – 3.08 B |
*derived from the ~200,000 ± 75,000/µL range.
Assumptions:
- Typical baseline platelet count is ~200,000 ± 75,000/µL (Low–mid–high corresponds to baseline platelet counts 125 / 200 / 275 ×10⁹/L).
- “Platelet recovery” reflects claimed capture/recovery where published:
- RegenLab: platelet recovery >80% (using 80% for calculation).
- Alocuro: average platelet collection efficiency ~90% (using 90%).
- EmCyte (120 mL): “up to 90% recovery” appears in supplier/distributor material (using 90%).
- Surecell: recovery % is not clearly published on the product pages; the value below is an illustrative estimate only (clearly labelled).
What this shows (and why it matters)
1) Whole-blood volume sets your “dose ceiling.”
A PRP system can only concentrate the platelets it has access to. If you process 10–30 mL of blood, you are starting with a much smaller platelet pool than a system processing 120 mL. Even with excellent recovery, the maximum achievable platelet dose is typically lower.
2) This is why “× baseline” can mislead.
A kit can produce “nice-looking” concentration numbers, but if the starting blood volume is small, the total platelets available to inject may still be modest. That’s exactly why PRP dosing discussions increasingly focus on total platelets delivered (dose), not concentration alone.
3) These numbers are not a substitute for measuring the final injectate.
This table estimates the recoverable platelet pool based on baseline platelet counts and claimed recovery. The true injected dose still depends on:
- the actual platelet concentration in the final PRP syringe (best measured by CBC/automated count),
- the final PRP volume injected, and
- any losses/variability in real-world processing.
Platelets aren’t just “clotting cells.” They’re biologic signalling packages that release a broad set of growth factors and cytokines involved in repair, angiogenesis, matrix remodelling, and cellular recruitment. PRP is designed to deliver these signals at supraphysiologic levels to a specific tissue target — which is why the dose of platelets delivered matters.
What to ask your PRP provider (the “dose and quality” checklist)
If you’re paying for PRP, you deserve to know what is being injected.
Here are the questions that matter:
1) How much whole blood is being collected?
This sets the ceiling for how many platelets are available to concentrate. If very little blood is drawn, there is a hard limit on the maximum platelet dose that can be delivered.
2) What platelet concentration are you injecting?
Ask for the actual measured number (typically platelets/mL or ×10⁹/L), not just “x-times baseline.”
3) What volume will be injected into the target?
The target volume varies by tissue and joint size. In some joints, excess fluid (effusion) may be aspirated first to make room for the injectate and optimise the local environment.
4) What is the total platelet dose delivered?
This is the most important metric:
Platelet dose = platelet concentration × injected volume.
Clinics may estimate this beforehand (based on expected yield and planned volume), but the best practice is to measure the final PRP platelet dose in the procedure record.
5) What is the PRP formulation (leukocyte-rich vs leukocyte-poor), and is there any red cell (RBC) contamination?
These factors can influence inflammation, proliferation, and tissue response, and should be intentionally chosen – not accidental.
If a clinic cannot answer these questions, they are effectively asking you to purchase a biologic therapy without knowing the dose – you would not take a drug where the dose varied by an order of magnitude.
Bottom Line: PRP should be judged by dose, not by the label
PRP is not a single treatment – it’s a dose-dependent biologic. If two clinics can both say “we do PRP” but cannot tell you the platelet dose delivered, you are not comparing like with like. You are comparing a label.
The evidence is moving in a clear direction: platelet dose correlates with outcomes. In moderate knee osteoarthritis, the most consistent long-term signal to date suggests a meaningful minimum threshold around ~10 billion platelets delivered. That does not mean every tissue needs 10 billion — it means results become far more predictable when PRP is treated as a real therapy: measured, reported, and dosed, rather than marketed as “5×” or “high strength.”
So the takeaway is simple:
- For patients: ask for concentration + volume + dose
- For clinics: measure final PRP + document dose
PRP should be judged the way every effective treatment in medicine is judged: what is delivered, in what amount, and with what quality control. Dose is the starting point — and precision is what turns PRP from a generic injection into a reproducible regenerative therapy.
In any dose-dependent therapy, dosing and documentation are non-negotiable.
Author: Dr Kirralee Sherif (PhD)
Related Articles
- What Is PRP Therapy and How Does It Work?
- Why PRP May Not Have Worked: Dose, Delivery, Diagnosis and Biology
- Treating Spinal Pain: A Precision Framework for PRP and Biologic Spine Treatments
- PRP for Knee Osteoarthritis
- How to Choose a High-Quality MRI Provider
- Does Medicare Cover PRP?
FAQ
Below are some questions related to PRP, if you have any other questions related to specialist interventional and diagnostic radiology or stem cell, cellular or other cutting edge regenerative therapies please visit our frequently asked questions page.
1) What is “platelet dose” in PRP?
Platelet dose is the total number of platelets delivered into the target tissue. It’s calculated as platelet concentration × injected volume.
2) Why do some people get no benefit from PRP?
Often because the injected product is not truly comparable to what effective studies used—especially if the platelet dose is low, preparation is inconsistent, or the indication/patient selection is mismatched [1,4].
3) What platelet dose should I aim for?
It depends on the tissue and condition, but for knee OA, multiple sources point toward higher-dose strategies and highlight thresholds around 10 billion total platelets for optimal outcomes in that indication. [4,5]
3) How can a clinic measure how many platelets are in my PRP?
By testing the final PRP on a blood analyser (CBC/automated platelet count) to get the platelet concentration, then multiplying by the injected volume to calculate the dose.
5) What is high-dose PRP?
High-dose PRP generally means PRP formulated to deliver a higher total platelet dose (more platelets injected), not just a higher “× baseline” concentration. In practice, it usually involves capturing more platelets from a larger blood draw and/or achieving higher platelet yield, then delivering an adequate injection volume to reach a higher total platelet number.
References
1. Everts PA, Lana JF, Onishi K, Buford D, Peng J, Mahmood A, et al. Angiogenesis and tissue repair depend on platelet dosing and bioformulation strategies following orthobiological platelet-rich plasma procedures: a narrative review. Biomedicines. 2023;11:1922. doi:10.3390/biomedicines11071922.
2. DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy. 2012;28(7):998-1009. doi:10.1016/j.arthro.2012.04.148.
3. Mautner K, Malanga GA, Smith J, Shiple B, Ibrahim V, Sampson S, et al. A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. PM R. 2015;7(4 Suppl):S53–S59. doi:10.1016/j.pmrj.2015.02.005.
4. Berrigan W, Tao F, Kopcow J, Park AL, Allen I, Tahir P, Reddy A, Bailowitz Z. The effect of platelet dose on outcomes after platelet rich plasma injections for musculoskeletal conditions: a systematic review and meta-analysis. Curr Rev Musculoskelet Med. 2024;17(12):570-588. doi:10.1007/s12178-024-09922-x.
5. Bansal H, Leon J, Pont JL, Wilson DA, Bansal A, Agarwal D, et al. Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: correct dose critical for long term clinical efficacy. Sci Rep. 2021;11:3971. doi:10.1038/s41598-021-83025-2.
6. Berrigan WA, Bailowitz Z, Park A, Reddy A, Liu R, Lansdown D. A greater platelet dose may yield better clinical outcomes for platelet-rich plasma in the treatment of knee osteoarthritis: a systematic review. Arthroscopy. 2025;41(3):809–817. doi:10.1016/j.arthro.2024.03.018.
7. Corsini A, Perticarini L, Palermi S, Bettinsoli P, Marchini A. Re-evaluating platelet-rich plasma dosing strategies in sports medicine: the role of the “10 billion platelet dose” in optimizing therapeutic outcomes—a narrative review. J Clin Med. 2025;14:2714. doi:10.3390/jcm14082714.
8. Bansal H, Leon J, Pont JL, Wilson DA, Bansal A, Agarwal D, et al. Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: correct dose critical for long term clinical efficacy. Sci Rep. 2021;11:3971. doi:10.1038/s41598-021-83025-2.
9. EmCyte. PUREPRP® TWO Protein Rich Platelet Concentrating System 120mL [Internet]. EmCyte; [cited 2026 Mar 6]. Available from: https://emcyte.com/product/pure-two-platelet-concentrating-system-120ml/
10. PRP Labs. EmCyte 120mL PURE TWO PRP Kit [Internet]. PRP Labs; [cited 2026 Mar 6]. Available from: https://prplabs.com/product/emcyte-120ml-pure-two-prp-kit/
11. EmCyte Corporation. Test Report: EmCyte PurePRP II (old vs new) [Internet]. [cited 2026 Mar 6]. Available from: https://static1.squarespace.com/static/536a7dcae4b0fe2bd2fb91f4/t/65de6168724e936d08addbba/1709072744443/Test%2BReport_%2BEmcyte%2BPurePRP%2BII_old%2Bvs%2Bnew.pdf
12. Alocuro. PRP Devices [Internet]. Alocuro; [cited 2026 Mar 6]. Available from: https://www.alocuro.com.au/prpdevices
13. Alocuro. Platelet Rich Plasma (PRP) [Internet]. Alocuro; [cited 2026 Mar 6]. Available from: https://www.alocuro.com.au/platelet-rich-plasma
14. Alocuro. Leukocyte Poor PRP [Internet]. Alocuro; [cited 2026 Mar 6]. Available from: https://www.alocuro.com.au/leukocyte-poor-prp
15. RegenLab. RegenPRP® [Internet]. RegenLab; [cited 2026 Mar 6]. Available from: https://www.regenlab.com/regenprp/
16. RegenLab. RegenKit® BCT MSK (Instructions/technical sheet) [Internet]. [cited 2026 Mar 6]. Available from: https://www.jointoperations.co.uk/wp-content/uploads/2024/04/RegenKit-BCT-MSK-MD-ENG-pp-1.pdf
17. Surecell. All Products (includes PRP tubes; 8 mL draw volume) [Internet]. Surecell; [cited 2026 Mar 6]. Available from: https://www.surecell.com.au/category/all-products
